Campylobacter jejuni enterocolitis presenting as inflammatory bowel disease.
We report a case of Campylobacter jejuni enterocolitis presenting as inflammatory bowel disease in a 19-year old woman. After a useless course of corticosteroids, ceftazidime and metronidazole, she was successfully treated with erythromicin. Campylobacter species represent an important cause of gastroenteritis in children and adults. The rate of Campylobacter isolation is 5-6 per 100,000 persons. This rate, however, grossly understimates the actual number of Campylobacter infections. In most cases, Campylobacter enteritis is a self-limiting disease, rarely associated with severe complications. Our case demonstrates the difficulty in distinguishing inflammatory bowel disease (Crohn's disease or ulcerative colitis) at onset from atypical infectious colitis. Unfortunately, corticosteroids (necessary for the treatment of inflammatory bowel disease) may exacerbate infectious etiologies. Campylobacter jejuni should be ruled out when assessing inflammatory bowel diseases at onset (as during flare-ups), especially if corticosteroids or immunosuppressive therapies are required.
Quondamcarlo
C
C
Division of Gastroenterology and Hepatology, Regina Apostolorum Hospital, Albano Laziale, Rome, Italy.
Valentini
G
G
Ruggeri
M
M
Forlini
G
G
Fenderico
P
P
Rossi
Z
Z
D000328:Adult; D002169:Campylobacter Infections / Q000175:diagnosis*; D016123:Campylobacter jejuni; D003937:Diagnosis, Differential; D004760:Enterocolitis / Q000175:diagnosis* / Q000382:microbiology; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis*